Argenx (ARGX) announced on Tuesday that the U.S. FDA has granted priority review for its marketing application aimed at ...
Argenx has announced that the US Food and Drug Administration has accepted for priority review a supplemental biologics ...
AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to ...
New sBLA for efgartigimod alfa-fcab aims to expand treatment for seronegative gMG patients who currently have limited medical options.
Myasthenia gravis is an autoimmune condition that weakens the muscles in your body. Acetylcholine is a neurotransmitter that helps your muscles move. Most people with generalized myasthenia gravis ...
In healthy people, binding of the molecule acetylcholine (ACh) to its receptor (AChR) on skeletal muscle cells triggers muscle contraction underlying regular daily activities. In the autoimmune ...
THOUSAND OAKS, Calif., March 13, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced new data from the Phase 3, registrational MINT trial evaluating the efficacy and safety of UPLIZNA ® ...
Ocular MG is a milder form of generalized MG, with lower AChR titers and less aggressive treatment needs. AChR titers above 100 nmol/L at diagnosis predict progression from ocular to generalized MG.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback